Home › Funds › Sectoral/Thematic mutual funds › WhiteOak Capital Pharma and Healthcare Fund
Equity · Sectoral/Thematic · WhiteOak Capital
WhiteOak Capital Pharma and Healthcare Fund
NAV, returns, holdings and category rank. Updated 6 Nov 2026.
WhiteOak Capital Pharma and Healthcare Fund is a Sectoral/Thematic fund from WhiteOak Capital. Over the last year it returned +20.8%. Its largest holdings are Divi's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd.
At a glance
What it holds
- Pharmaceuticals & Biotechnology 55%
- Healthcare Services 21%
- Chemicals & Petrochemicals 3%
- Consumer Durables 2%
- Healthcare 1%
- Healthcare Equipment & Supplies 1%
- Other / cash 16%
84% in shares across 50 stocks. Biggest: Divi's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd.
Last five years
How bumpy
Worst fall in five years
In past market falls
From AMFI NAV history (via mfapi.in) and NSE's Nifty 50 month-end levels, price only. Past performance may or may not be sustained in future. A description of the past, not a rating or a recommendation.
| Plan | NAV | 1 year | 3 years a yr | 5 years a yr | 3Y rank |
|---|---|---|---|---|---|
| Regular | ₹17.094 | +20.80% | — | — | — |
| Direct | ₹17.932 | +22.90% | — | — | — |
1-year figures are absolute returns; 3 and 5-year figures are yearly compounded. Growth options, from AMFI's NAVs. Ranks compare the same plan within the category by past return; they are not a rating.
What WhiteOak Capital Pharma and Healthcare Fund owns
50 stocks, 83.8% of the fund in shares, from the portfolio WhiteOak Capital disclosed for September 2026.
Top 10 holdings
Sector mix
Other Sectoral/Thematic mutual funds
| Fund | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Taiwan Equity Fund | +37.70% | +39.31% | — |
| HDFC Defence Fund | +19.63% | +33.15% | — |
| HDFC Pharma and Healthcare Fund | +26.81% | +29.76% | — |
| SBI Healthcare Opportunities Fund | +21.11% | +24.01% | +18.53% |
| HDFC Transportation and Logistics Fund | +8.74% | +23.48% | — |
| UTI Healthcare Fund | +17.70% | +23.19% | +15.83% |
| Mirae Asset Healthcare Fund | +22.57% | +23.03% | +15.61% |
| ICICI Prudential Healthcare Fund | +8.48% | +21.78% | +16.32% |
See all 255 Sectoral/Thematic mutual funds ranked
Questions
What is the NAV of WhiteOak Capital Pharma and Healthcare Fund?
The regular plan's NAV was ₹17.094 on 6 Nov 2026. The direct plan's NAV was ₹17.932 on 6 Nov 2026.
What returns has WhiteOak Capital Pharma and Healthcare Fund given?
Regular plan: +20.8% over 1 year, — a year over 3 years and — a year over 5 years, as of 6 Nov 2026. Past performance may or may not be sustained in future.
Which stocks does WhiteOak Capital Pharma and Healthcare Fund hold?
As disclosed for September 2026, its top holdings were Divi's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd, out of 50 stocks.
Should I choose the regular or the direct plan?
Both plans hold the same portfolio. The direct plan has a lower expense ratio; the regular plan is bought through a distributor, who is paid a commission and helps you choose, invest and keep track.